Financials
- Market Capitalization 1.49 B
- Employee 87
- Founded 2018
- CEO N/A
- Website www.tyra.bio
- Headquarter Delaware, United States
- FIGI BBG00RCQD9D1
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-13.08
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2192 | ABSI Absci Corporation - Common Stock | 8.71 USD | -7.54% | -6.65% | +24.43% | +270.64% | 1.49 B USD | ||
| 2197 | AVBP ArriVent BioPharma, Inc. - Common Stock | 30.17 USD | -2.68% | +3.96% | -0.40% | +55.92% | 1.49 B USD | ||
| 2206 | REPL Replimune Group, Inc. - Common Stock | 15.50 USD | -0.64% | +5.95% | +36.20% | +180.80% | 1.46 B USD | ||
| 2236 | CGEM Cullinan Therapeutics, Inc. - Common Stock | 21.70 USD | -3.98% | +0.37% | +25.07% | +189.33% | 1.40 B USD |